Tilray Brands (TLRY) Change in Receivables (2017 - 2026)
Tilray Brands (TLRY) reported Change in Receivables of $9.3 million for Q1 2026, up 199.24% on a YoY basis from $3.1 million in Q1 2025, and up 365.98% quarter-over-quarter from $2.0 million in Q4 2025.
Tilray Brands (TLRY) Change in Receivables (2017 - 2026) Analysis & Trends
Tilray Brands has reported Change in Receivables for 10 years, with the latest figure at $9.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 199.24% year-over-year to $9.3 million; the trailing twelve-month figure through Feb 2026 stood at $15.0 million (up 26.82% YoY), and the FY2025 full-year result was $17.8 million, up 170.74% from the prior year.
- Change in Receivables for Q1 2026 stood at $9.3 million, up from $2.0 million in the prior quarter.
- The five-year high for Change in Receivables was $18.1 million in Q2 2025, with the low at -$14.4 million in Q3 2025.
- Historically, Change in Receivables has averaged $1.5 million across 5 years, with a median of $3.1 million in 2022.
- Annual changes were most pronounced in 2025 — Change in Receivables sank 789.18% — and 2026, when it surged 199.24%.
- Tilray Brands' Change in Receivables stood at -$9.8 million in 2022, then soared by 187.31% to $8.5 million in 2023, then retreated by 21.26% to $6.7 million in 2024, then plunged by 70.25% to $2.0 million in 2025, then soared by 365.98% to $9.3 million in 2026.
- The last three Change in Receivables figures came in at $9.3 million (Q1 2026), $2.0 million (Q4 2025), and -$14.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 9.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 9.30 Mn |
| Feb 28, 2026 | 9.30 Mn |
| Nov 30, 2025 | 2.00 Mn |
| Nov 30, 2025 | 2.00 Mn |
| Aug 31, 2025 | -14.41 Mn |
| Aug 31, 2025 | -14.41 Mn |
| May 31, 2025 | 18.12 Mn |
| May 31, 2025 | 18.12 Mn |
| Feb 28, 2025 | -9.37 Mn |
| Feb 28, 2025 | -9.37 Mn |
| Nov 30, 2024 | 6.71 Mn |
| Nov 30, 2024 | 6.71 Mn |
| Aug 31, 2024 | 2.34 Mn |
| Aug 31, 2024 | 2.34 Mn |
| May 31, 2024 | 12.15 Mn |
| May 31, 2024 | 12.15 Mn |
| Feb 29, 2024 | -1.05 Mn |
| Feb 29, 2024 | -1.05 Mn |
| Nov 30, 2023 | 8.52 Mn |
| Nov 30, 2023 | 8.52 Mn |